Cancer Detection and Diagnosis Research in Oregon
Cancer Detection and Diagnosis Research (93.394) awarded $36.1 million to recipients in Oregon in 25 grants from fiscal 2021 to 2025, 1.3% of the program's national total. Oregon Health & Science University received the most, $30.5 million.
- Awarded in Oregon$36.1 million
- Awards25
- Share of the program1.3%
- Rank among states19th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 10 | $6.0 million |
| FY 2022 | 11 | $6.0 million |
| FY 2023 | 13 | $7.2 million |
| FY 2024 | 15 | $7.6 million |
| FY 2025 | 13 | $9.3 million |
Recipients in Oregon
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Oregon Health & Science University | Colleges and universities | 19 | $30.5 million |
| Oregon State University | Colleges and universities | 2 | $3.8 million |
| Trace Biosciences Inc | Small businesses | 2 | $1.2 million |
| Omnecoil Instruments, Inc. | Small businesses | 1 | $399,995 |
| PDX Pharmaceuticals Inc | Small businesses | 1 | $250,000 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Oregon?
$36.1 million from fiscal 2021 to 2025, across 25 awards. Oregon ranks 19th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Oregon?
The largest recipient is Oregon Health & Science University, with $30.5 million in 19 awards. Next are Oregon State University and Trace Biosciences Inc.
Can organizations in Oregon apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Oregon
- Grants to States for Medicaid
- Highway Planning and Construction
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- National School Lunch Program
- Federal Transit Formula Grants
- Head Start
- Temporary Assistance for Needy Families
- Child Care and Development Block Grant